论文部分内容阅读
目的探讨转移因子口服液辅助治疗小儿反复呼吸道感染的临床效果。方法选取忻城县人民医院2013年1月至2014年6月收治的反复呼吸道感染患儿116例作为研究对象,并随机均分为两组,对照组(58例)予以常规治疗,观察组(58例)在此基础上辅以转移因子口服液治疗,比较两组的临床效果。结果治疗后,观察组退热时间减短[(3.20±1.25)d]、复发次数减少[(1.50±1.50)次]、总显效率增高(93.10%),与对照组比较差异有统计学意义(P<0.05)。结论转移因子口服液辅助治疗小儿反复呼吸道感染临床效果确切,值得推广应用。
Objective To investigate the clinical effect of transfer factor oral liquid adjuvant treatment of children with recurrent respiratory tract infection. Methods One hundred and sixty-six children with recurrent respiratory tract infection admitted to Xincheng County People’s Hospital from January 2013 to June 2014 were selected and randomly divided into two groups. The control group (58 cases) was treated routinely. The observation group (n = 58 cases) on this basis supplemented by transfer factor oral solution treatment, the clinical efficacy of the two groups were compared. Results After treatment, the observation group had shorter antipyretic time (3.20 ± 1.25) d and fewer recurrences (1.50 ± 1.50), and the total effective rate increased significantly (93.10%) compared with the control group (P <0.05). Conclusion The transfer factor oral solution adjuvant treatment of children with recurrent respiratory tract infection clinical effect is exact, it is worth to promote the application.